|
| |
Image Results
Loading...
Loading...
Mylan Laboratories Matrix Pages on BioPortfolio:
|
Biotechnology News LAMIVUDINE Search
Mylan announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. ...
http://www.bioportfolio.co.uk/LAMIVUDINE-news.htm...
|
BioPortfolio News: Mylan Inc. - Mylan Reports Third Quarter ...
The Matrix segment had consisted of Matrix Laboratories Limited, which had been a publicly traded Indian Company in which Mylan held a 71.2% ownership stake ...
http://www.bioportfolio.com/news/Mylan-Reports-Third-Quarter...
|
Biotechnology News RIMSO-50 Search
today announced in a press release that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license ...
http://www.bioportfolio.co.uk/RIMSO-50-news.htm...
|
BioPortfolio - Matrix Laboratories Limited - Profile
BioNews Results for Matrix Laboratories Limited. • Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and ...
http://www.bioportfolio.com/biocorporate/26043-Matrix%252525...
|
Biotechnology News Matrix Group Search
4 Aug 2009 ... Daiichi wins court battle against Mylan, Matrix ... Benicar, against Mylan Inc and its Indian subsidiary, Matrix Laboratories. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Mylan Inc. - Mylan Announces Intention to Purchase ...
Mylan Announces Intention to Purchase. Remaining Interest in Matrix Laboratories and. Delist Matrix from Indian Stock Exchanges ...
http://www.bioportfolio.com/news/Mylan_Announces_Intention_t...
|
BioPortfolio - Mylan Inc. - Mylan Confirms Four First-to-File ...
Mylan, Mylan Pharmaceuticals and Matrix Laboratories Limited, in which Mylan owns a majority interest, were sued by Shire Canada Inc., Shire International
...
http://www.bioportfolio.com/news/Mylan_Confirms_Four_First-t...
| Results from other life science and pharmaceutical sites:
Mylan Laboratories Completes Matrix Laboratories Transaction ...
Pittsburgh, PA and Hyderabad, India: January 8, 2007 - Mylan Laboratories Inc. ( NYSE: MYL) and Matrix Laboratories Limited (Mumbai Stock Exchange, 524794; ...
http://www.matrixlabsindia.com/inside/090107.asp...
|
Mylan Laboratories Inc. Completes Matrix Laboratories Limited ...
9 Jan 2007 ... 8 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. and Matrix Laboratories Limited (Mumbai Stock Exchange, 524794; National Stock Exchange, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=42047...
|
Matrix Laboratories Limited
Matrix Laboratories Appoints S. Srinivasan as Managing Director and CEO, Promotes B. Hari Babu, Ph.D., to Chief Operating Officer ...
http://www.matrixlabsindia.com/...
|
Mylan Inc.'s Matrix Laboratories Limited Wins FDA's First ...
31 Mar 2009 ... PITTSBURGH, March 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL - News) today announced that Matrix Laboratories Limited, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=132974...
|
Milestones - Matrix Laboratories Limited
Successful Delisting offer by Mylan. January 2007. Mylan Laboratories Acquire Up to 71.5% Controlling Interest in Matrix Laboratories. January 2007 ...
http://www.matrixlabsindia.com/inside/milestones.asp...
|
MYL: Profile for Mylan Inc. - Yahoo! Finance
The Matrix segment offers APIs and finished dosage forms, ... The company was formerly known as Mylan Laboratories Inc. and changed its name to Mylan Inc. ...
http://biz.yahoo.com/p/M/MYL.html...
|
Matrix Laboratories Limited
Matrix Laboratories Limited, a subsidiary of Mylan Inc., USA, is a public limited company listed on BSE and NSE, and is engaged in the manufacture of
Active ...
http://www.matrixlabsindia.com/inside/280208.asp...
|
Mylan Inc. - Google Finance
... the Company held a 71.2% interest in Matrix Laboratories Limited (Matrix). ... Mylan has three segments: the Generics Segment, the Matrix Segment and ...
http://www.google.com/finance?q=NASDAQ:MYL...
|
BioSpace - Matrix Laboratories Limited News, Search Jobs, Events
6 Dec 2005 ... Mylan Inc. (MYL) to Pay $133 Million for Rest of Matrix Laboratories Limited ( MAXL.BO) 3/26/2009 11:36:40 AM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=73782...
|
Mylan Settles Dispute with Pfizer - Yahoo! Finance
15 Oct 2009 ... Mylan's subsidiary, Matrix Laboratories, has Food and Drug Administration (FDA) approval for the generic version of the drug. ...
http://biz.yahoo.com/zacks/091015/25989.html?.v=1...
|
|
